Near tetraploid prostate carcinoma. Methodologic and prognostic aspects
- PMID: 8859188
Near tetraploid prostate carcinoma. Methodologic and prognostic aspects
Abstract
Background: The clinical value of DNA ploidy analysis in prostate carcinoma has been an issue for investigation for more than 2 decades. In general, diploid or pseudodiploid tumors are associated with a favorable prognosis and aneuploid tumors with an unfavorable prognosis, irrespective of type of treatment. Tumors with DNA values in the tetraploid region (around 4c) present a diagnostic problem. Such DNA distributions may clearly represent aneuploid tumors with an unfavorable prognosis. However, a 4c distribution may conversely represent a tetraploid tumor (possibly a polyploid variant of the diploid tumor) with a favorable prognosis. Previous data from our laboratory indicate the existence of such a tetraploid subgroup. The goal of the current study was to investigate the diagnostic problem of 4c tumors in greater detail.
Methods: Ploidy classification of cytologic smears by image cytometry was performed in a retrospective study of 334 patients with hormonally treated prostate carcinoma. Follow-up time was 30 years or until death.
Results: Three ploidy types were defined: near-diploid (D type), near-tetraploid (T type), and highly aneuploid (A type). Tumors with a modal value within the tetraploid region were found in 27% (92 cases) of the total material. Of these, 9% were defined as T type and 18% as A type. Overall, 37% of the tumors were classified as D type, 9% as T type, and 54% as A type. Of the A type tumors, one-third had modal DNA values in the tetraploid (4c) region. Multivariate analysis showed a statistically significant difference between A type tumors and D and T type, but not between D type and T type. Both D and T type tumors progressed slowly and killed the patients 5 to 30 years after diagnosis, whereas A type tumors progressed rapidly and killed the patients within 6 years of diagnosis.
Conclusions: By image cytometry, prostate carcinoma can be divided into three ploidy types: D, T, and A type. Biologically, however, the tumors fall into only two groups: low grade malignant, pseudodiploid tumors of D or T type, and high grade malignant, highly aneuploid tumors of A type.
Similar articles
-
Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma.Cancer Res. 1990 Jul 15;50(14):4281-5. Cancer Res. 1990. PMID: 1694718
-
A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.Urology. 1997 Sep;50(3):379-84. doi: 10.1016/S0090-4295(97)00223-9. Urology. 1997. PMID: 9301701
-
Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.Cancer. 1997 Jun 1;79(11):2073-86. Cancer. 1997. PMID: 9179053
-
Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.Scand J Urol Nephrol Suppl. 1994;162:51-63; discussion 15-27. Scand J Urol Nephrol Suppl. 1994. PMID: 7529429 Review.
-
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.APMIS Suppl. 2003;(108):1-67. APMIS Suppl. 2003. PMID: 12874968 Review.
Cited by
-
Genomic instability and proliferative activity as risk factors for distant metastases in breast cancer.Br J Cancer. 2008 Aug 5;99(3):513-9. doi: 10.1038/sj.bjc.6604479. Br J Cancer. 2008. PMID: 18665192 Free PMC article.
-
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.Sci Transl Med. 2010 Jun 30;2(38):38ra47. doi: 10.1126/scitranslmed.3000611. Sci Transl Med. 2010. PMID: 20592421 Free PMC article.
-
Novel patterns of genome rearrangement and their association with survival in breast cancer.Genome Res. 2006 Dec;16(12):1465-79. doi: 10.1101/gr.5460106. Genome Res. 2006. PMID: 17142309 Free PMC article.
-
RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability.Neuro Oncol. 2011 Dec;13(12):1277-87. doi: 10.1093/neuonc/nor131. Epub 2011 Sep 16. Neuro Oncol. 2011. PMID: 21926087 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical